Clifton Anderson, n/a

Scientist II
Simulations Plus

Poster(s):

• (M-014) Multiple myeloma QSP model enables evaluation of iberdomide dosing schedules post-ASCT in NDMM patients for the EXCALIBER Maintenance study
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT

• (M-015) Hybrid MBMA-QSP Model Predicts T Cell Engager Plus Cereblon E3 Ligase Modulatory Drugs Combination Outcomes As A Function Of Prior Therapies In Relapsed/refractory Multiple Myeloma
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT